National Pension Service increased its holdings in Agilent Technologies Inc (NYSE:A) by 1.1% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 457,901 shares of the medical research company’s stock after purchasing an additional 5,084 shares during the quarter. National Pension Service owned 0.15% of Agilent Technologies worth $32,795,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of A. The Manufacturers Life Insurance Company increased its position in shares of Agilent Technologies by 10.6% during the first quarter. The Manufacturers Life Insurance Company now owns 328,241 shares of the medical research company’s stock valued at $23,509,000 after acquiring an additional 31,582 shares during the last quarter. Samlyn Capital LLC purchased a new position in shares of Agilent Technologies in the 1st quarter valued at about $48,626,000. HighTower Advisors LLC grew its holdings in Agilent Technologies by 31.0% during the 1st quarter. HighTower Advisors LLC now owns 145,019 shares of the medical research company’s stock worth $10,366,000 after acquiring an additional 34,308 shares in the last quarter. Maverick Capital Ltd. acquired a new position in shares of Agilent Technologies during the 1st quarter worth about $3,867,000. Finally, Waddell & Reed Financial Inc. boosted its holdings in Agilent Technologies by 2.5% in the first quarter. Waddell & Reed Financial Inc. now owns 1,042,419 shares of the medical research company’s stock valued at $74,658,000 after purchasing an additional 25,617 shares in the last quarter.

Several brokerages have weighed in on A. Stifel Nicolaus lowered their target price on Agilent Technologies from $85.00 to $73.00 and set a “hold” rating on the stock in a research note on Thursday, April 2nd. UBS Group boosted their price target on Agilent Technologies from $84.00 to $87.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. Barclays lowered their price objective on shares of Agilent Technologies from $85.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 26th. Citigroup dropped their price target on Agilent Technologies from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, March 20th. Finally, Cfra dropped their target price on Agilent Technologies from $89.00 to $85.00 and set a “hold” rating for the company in a research note on Friday, May 22nd. Eleven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $85.75.

Shares of A traded down $1.03 on Friday, hitting $86.23. The company’s stock had a trading volume of 8,520 shares, compared to its average volume of 1,747,852. The company has a 50 day moving average price of $85.55 and a 200 day moving average price of $81.55. Agilent Technologies Inc has a fifty-two week low of $61.13 and a fifty-two week high of $93.04. The company has a market capitalization of $26.73 billion, a PE ratio of 40.26, a PEG ratio of 2.78 and a beta of 1.13. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.63 and a quick ratio of 1.24.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.10. Agilent Technologies had a return on equity of 20.76% and a net margin of 13.04%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter last year, the business earned $0.71 earnings per share. The firm’s quarterly revenue was up .2% compared to the same quarter last year. On average, equities analysts forecast that Agilent Technologies Inc will post 3.11 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Monday, June 29th. Agilent Technologies’s dividend payout ratio is currently 23.15%.

In related news, CEO Michael R. Mcmullen sold 8,814 shares of Agilent Technologies stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $76.20, for a total transaction of $671,626.80. Following the completion of the transaction, the chief executive officer now owns 542,848 shares in the company, valued at $41,365,017.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Rodney Gonsalves sold 4,566 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $85.30, for a total value of $389,479.80. Following the transaction, the vice president now directly owns 102,806 shares in the company, valued at $8,769,351.80. The disclosure for this sale can be found here. Insiders have sold a total of 64,426 shares of company stock worth $5,300,943 in the last quarter.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Story: What are the reasons investors use put options?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.